{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26265981", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "19"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2015", "Month": "07", "Day": "21"}], "ELocationID": ["190640", "10.1155/2015/190640"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2015", "PubDate": {"Year": "2015"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Daily Oxygen/O\u2083 Treatment Reduces Muscular Fatigue and Improves Cardiac Performance in Rats Subjected to Prolonged High Intensity Physical Exercise.", "Pagination": {"StartPage": "190640", "MedlinePgn": "190640"}, "Abstract": {"AbstractText": ["Rats receiving daily intraperitoneal administration of O2 and running on a treadmill covered an average distance of 482.8 \u00b1 21.8\u2009m/week as calculated during 5-week observation. This distance was increased in rats receiving daily intraperitoneal administration of an oxygen/O3 mixture at a dose of 100; 150; and 300\u2009\u03bcg/kg with the maximum increase being +34.5% at 300\u2009\u03bcg/kg and still present after stopping the administration of oxygen/O3. Oxygen/O3 decreased the mean arterial blood pressure (-13%), the heart rate (-6%), the gastrocnemius and cardiac hypertrophy, and fibrosis and reduced by 49% the left ventricular mass and relative wall thickness measurements. Systolic and diastolic functions were improved in exercised oxygen/O3 rats compared to O2 rats. Oxygen/O3 treatment led to higher MPI index starting from the dose of 150\u2009\u03bcg/kg (p < 0.05) and more effective (+14%) at a dose of 300\u2009\u03bcg/kg oxygen/O3. Oxygen/O3 dose-dependently increased the expression of the antioxidant enzymes Mn-SOD and GPx1 and of eNOS compared to the exercised O2 rats. The same doses resulted in decrease of LDH levels, CPK, TnI, and nitrotyrosine concentration in the heart and gastrocnemius tissues, arguing a beneficial effect of the ozone molecule against the fatigue induced by a prolonged high intensity exercise."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology \"L. Donatelli\", Second University of Naples, 80138 Naples, Italy."}], "LastName": "Di Filippo", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology \"L. Donatelli\", Second University of Naples, 80138 Naples, Italy."}], "LastName": "Trotta", "ForeName": "M C", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology \"L. Donatelli\", Second University of Naples, 80138 Naples, Italy."}], "LastName": "Maisto", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology \"L. Donatelli\", Second University of Naples, 80138 Naples, Italy."}], "LastName": "Siniscalco", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anaesthetic, Surgical and Emergency Sciences, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Luongo", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anaesthetic, Surgical and Emergency Sciences, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Mascolo", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anaesthetic, Surgical and Emergency Sciences, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Alfano", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical and Mental Health and Preventive Medicine, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Accardo", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department Magrassi-Lanzara, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Rossi", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical and Mental Health and Preventive Medicine, Second University of Naples, 80138 Naples, Italy."}], "LastName": "Ferraraccio", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology \"L. Donatelli\", Second University of Naples, 80138 Naples, Italy."}], "LastName": "D'Amico", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Troponin I"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.1.1.27", "NameOfSubstance": "L-Lactate Dehydrogenase"}, {"RegistryNumber": "EC 1.11.1.9", "NameOfSubstance": "Glutathione Peroxidase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "EC 2.7.3.2", "NameOfSubstance": "Creatine Kinase"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["metabolism"], "DescriptorName": "Creatine Kinase"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Fibrosis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione Peroxidase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart Rate"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Hypertrophy"}, {"QualifierName": ["metabolism"], "DescriptorName": "L-Lactate Dehydrogenase"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Fatigue"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Muscle, Skeletal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Oxygen"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Physical Conditioning, Animal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Troponin I"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kemi O. J., Haram P. M., Loennechen J. P., et al. Moderate vs. high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function. Cardiovascular Research. 2005;67(1):161\u2013172. doi: 10.1016/j.cardiores.2005.03.010.", "ArticleIdList": ["10.1016/j.cardiores.2005.03.010", "15949480"]}, {"Citation": "Pluim B. M., Zwinderman A. H., van der Laarse A., van der Wall E. E. The athlete's heart: a meta-analysis of cardiac structure and function. Circulation. 2000;101(3):336\u2013344. doi: 10.1161/01.cir.101.3.336.", "ArticleIdList": ["10.1161/01.cir.101.3.336", "10645932"]}, {"Citation": "Davies K. J. A., Quintanilha A. T., Brooks G. A., Packer L. Free radicals and tissue damage produced by exercise. Biochemical and Biophysical Research Communications. 1982;107(4):1198\u20131205. doi: 10.1016/s0006-291x(82)80124-1.", "ArticleIdList": ["10.1016/s0006-291x(82)80124-1", "6291524"]}, {"Citation": "Ashton T., Rowlands C. C., Jones E., et al. Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise. European Journal of Applied Physiology and Occupational Physiology. 1998;77(6):498\u2013502. doi: 10.1007/s004210050366.", "ArticleIdList": ["10.1007/s004210050366", "9650733"]}, {"Citation": "Ashton T., Young I. S., Peters J. R., et al. Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid intervention study. Journal of Applied Physiology. 1999;87(6):2032\u20132036.", "ArticleIdList": ["10601146"]}, {"Citation": "Knez W. L., Jenkins D. G., Coombes J. S. Oxidative stress in half and full Ironman triathletes. Medicine and Science in Sports and Exercise. 2007;39(2):283\u2013288. doi: 10.1249/01.mss.0000246999.09718.0c.", "ArticleIdList": ["10.1249/01.mss.0000246999.09718.0c", "17277592"]}, {"Citation": "Elvis A. M., Ekta J. S. Ozone therapy: a clinical review. Journal of Natural Science, Biology and Medicine. 2011;2(1):66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Razumovskii Z. Ozone and its reactions with organic compounds.  1984,  http://ozonicsint.com/articlesvivo.html."}, {"Citation": "Folinsbee L. J. Effects of ozone exposure on lung function in man. Reviews on Environmental Health. 1981;3(3):211\u2013240.", "ArticleIdList": ["7330364"]}, {"Citation": "Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? British Journal of Biomedical Science. 1999;56(4):270\u2013279.", "ArticleIdList": ["10795372"]}, {"Citation": "Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for the therapy of human immunodeficiency virus infection and several other diseases. Medical Hypotheses. 1996;46(2):150\u2013154. doi: 10.1016/s0306-9877(96)90016-x.", "ArticleIdList": ["10.1016/s0306-9877(96)90016-x", "8692040"]}, {"Citation": "Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radical Research. 2012;46(9):1068\u20131075. doi: 10.3109/10715762.2012.693609.", "ArticleIdList": ["10.3109/10715762.2012.693609", "22583557"]}, {"Citation": "Borrelli E., Bocci V. A novel terapeutic option for Chronic Fatigue Syndrome and Fibromyalgia. Rivista Italiana di Ossigeno-Ozonoterapia. 2002;1:149\u2013153."}, {"Citation": "Di Filippo C., Marfella R., Capodanno P., et al. Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct. Inflammation Research. 2008;57(10):445\u2013449. doi: 10.1007/s00011-008-7237-0.", "ArticleIdList": ["10.1007/s00011-008-7237-0", "18827966"]}, {"Citation": "Lana A. D. C., Paulino C. A., Gon\u00e7alves I. D. Influence of low and high intensity physical exercise on hypernociception threshold and other parameters of rats. Revista Brasileira de Medicina do Esporte. 2006;12(5)"}, {"Citation": "Coppola L., Giunta R., Verrazzo G., et al. Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies. Diabete et Metabolisme. 1995;21(4):252\u2013255.", "ArticleIdList": ["8529759"]}, {"Citation": "Chen H., Xing B., Liu X., et al. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. Journal of Surgical Research. 2008;149(2):287\u2013295. doi: 10.1016/j.jss.2007.12.756.", "ArticleIdList": ["10.1016/j.jss.2007.12.756", "18262565"]}, {"Citation": "Morsy M. D., Hassan W. N., Zalat S. I. Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabetology & Metabolic Syndrome. 2010;2, article 29 doi: 10.1186/1758-5996-2-29.", "ArticleIdList": ["10.1186/1758-5996-2-29", "PMC2880015", "20465785"]}, {"Citation": "Torossian A., Ruehlmann S., Eberhart L., Middeke M., Wulf H., Bauhofer A. Pre-treatment with ozonized oxygen (O3) aggravates inflammation in septic rats. Inflammation Research. 2004;53(2):S122\u2013S125.", "ArticleIdList": ["15338062"]}, {"Citation": "Re L., Mawsouf M. N., Men\u00e9ndez S., Le\u00f3n O. S., S\u00e1nchez G. M., Hern\u00e1ndez F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Archives of Medical Research. 2008;39(1):17\u201326. doi: 10.1016/j.arcmed.2007.07.005.", "ArticleIdList": ["10.1016/j.arcmed.2007.07.005", "18067991"]}, {"Citation": "Bellamy L. M., Joanisse S., Grubb A., et al. The acute satellite cell response and skeletal muscle hypertrophy following resistance training. PLoS ONE. 2014;9(10) doi: 10.1371/journal.pone.0109739.e109739", "ArticleIdList": ["10.1371/journal.pone.0109739", "PMC4196938", "25313863"]}, {"Citation": "Hernandez F., Menendez S., Wong R. Decrease of blood cholesterol and stimulation of antioxidative response on cardiopathy patients treated with endovenous ozone therapy. Free Radical Biology & Medicine. 1995;19:115\u2013119.", "ArticleIdList": ["7635353"]}, {"Citation": "Bocci V., Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Frontiers in Chemistry. 2015;3, article 4 doi: 10.3389/fchem.2015.00004.", "ArticleIdList": ["10.3389/fchem.2015.00004", "PMC4313773", "25699252"]}, {"Citation": "Albrecht E. W. J. A., Stegeman C. A., Heeringa P., Henning R. H., van Goor H. Protective role of endothelial nitric oxide synthase. The Journal of Pathology. 2003;199(1):8\u201317. doi: 10.1002/path.1250.", "ArticleIdList": ["10.1002/path.1250", "12474221"]}, {"Citation": "Hill B. G., Dranka B. P., Bailey S. M., Lancaster J. R., Jr., Darley-Usmar V. M. What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. The Journal of Biological Chemistry. 2010;285(26):19699\u201319704. doi: 10.1074/jbc.r110.101618.", "ArticleIdList": ["10.1074/jbc.r110.101618", "PMC2888379", "20410298"]}, {"Citation": "Villanueva C., Giulivi C. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radical Biology and Medicine. 2010;49(3):307\u2013316. doi: 10.1016/j.freeradbiomed.2010.04.004.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.04.004", "PMC2900489", "20388537"]}, {"Citation": "Cooke J. P., Dzau V. J. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation. 1997;96(2):379\u2013382.", "ArticleIdList": ["9244195"]}, {"Citation": "Beckman J. S., Koppenol W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. American Journal of Physiology: Cell Physiology. 1996;271(5):C1424\u2013C1437.", "ArticleIdList": ["8944624"]}, {"Citation": "Zamora R., Vodovotz Y., Billiar T. R. Inducible nitric oxide synthase and inflammatory diseases. Molecular Medicine. 2000;6(5):347\u2013373.", "ArticleIdList": ["PMC1949959", "10952018"]}, {"Citation": "Chatterjee A., Catravas J. D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascular Pharmacology. 2008;49(4\u20136):134\u2013140. doi: 10.1016/j.vph.2008.06.008.", "ArticleIdList": ["10.1016/j.vph.2008.06.008", "PMC2592563", "18692595"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "5", "Day": "26"}, {"Year": "2015", "Month": "6", "Day": "28"}, {"Year": "2015", "Month": "8", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "7", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26265981", "PMC4523667", "10.1155/2015/190640"]}}], "PubmedBookArticle": []}